Norway· NO-ID_C5A3BEBE-CE52-40F0-A87B-2D0AB9A0B70F

Miniderm

A other emollients and protectives product containing glycerol, registered in Norway by Aco Hud Nordic AB. The same ATC class is registered in 7 of our 19 countries.

ATC D02AX

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedMinidermATCD02AXREGISTER NO.NO-ID_C5A3BEBE-CE52-4…PACKS LISTED5CHECKEDSeptember 25, 2026

Where it is registered

Glycerol is registered in 7 of 19 countries.

Countries holding a registration under ATC D02AX (other emollients and protectives), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 5 of them publish a price we can compare per daily dose

Glycerol · ATC D02AX

7 / 19 countries

  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Glycerol
Manufacturer
Aco Hud Nordic AB
Country
Norway (NO)
ATC code
D02AX
ATC class
Other emollients and protectives
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 5

  • no_merkevare_id
    ID_C5A3BEBE-CE52-40F0-A87B-2D0AB9A0B70F
  • no_varenummer
    067905
    100
  • no_varenummer
    067914
    500
  • gtin
    7319860679053
  • gtin
    7319860679145

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Glycerol in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glycerol products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Glyzerin Rösch
  • Belgium · Fagrocerine Adultes, Fagrocerine Enfants
  • Cyprus · Βρεφικα / Ζαρμπη, Βρεφικα/ Ζαρμπη
  • Czechia · Suppositoria Glycerini Mayoly Pharma France
  • Germany · Babylax Rektallösung, Glycilax Für Erwachsene
  • Denmark · Glycerol "oba", Miniderm
  • Spain · Adulax, Glicerina Adultos Vilardell
  • France · Bebegel, Cristal Adultes
  • United Kingdom (Northern Ireland) · Asda Children’s Dry Cough Blackcurrant Flavour, Bell’s Children’s Cough Blackcurrant Flavour
  • Greece · Glicerolo Microclismi, Medilax
  • Croatia · Prolax
  • Hungary · Glicerin Teva, Glycerol Izotóniás Nacl Oldatban Teva
  • Ireland · Glycerol Ethypharm, Lemsip Dry Cough
  • Italy · Clarilax Stitichezza Adulti, Clarilaxina Stitichezza Adulti
  • Malta · Glycerol Children Sella, Glycerol Sella Adults
  • Poland · Avenalax 1g, Avenalax 2g
  • Portugal · Bebegel, Dagragel
  • Romania · Glicerina Pentru Adulti Antibiotice Sa, Glicerină Pentru Adulți Tis Farmaceutic
  • Sweden · Cremarol, Glycerol Evolan
  • Slovakia · Suppositoria Glycerini

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bc18afbe-1471-4b72-a354-ffe883fa7426
GET /v1/drugs/bc18afbe-1471-4b72-a354-ffe883fa7426?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "fest",
  "status": "A",
  "atc_name": "Diverse bløtgjørende og hudbeskyttende midler",
  "merkevare_id": "ID_C5A3BEBE-CE52-40F0-A87B-2D0AB9A0B70F",
  "name_form_strength": "Miniderm krem 20 %",
  "prescription_group": "F"
}

See everything about glycerol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.